Recent Updates
Recently added Catalysts
ENOV Positive Sentiment

Enovis to Host Second Quarter 2023 Results Conference Call on August 3rd

Key Takeaway: Enovis Corporation announced it will hold an investor conference call on August 3, 2023, at 8:30 a.m. Eastern Time to discuss its second quarter 2023 financial results. A press release will be issued earlier that day, and a related presentation will be available on their website. The call aims to provide insights into the company's performance and future strategies.
Price reaction · baseline $64.37 (2023-07-10 close) · hit after-hours · clean, no other ENOV news in the window
day 0 close · peak
+0.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Enovis is hosting a conference call to discuss positive financial results.
  • The company is focused on innovation and improving patient outcomes.
  • Enovis is preparing for investor engagement which may enhance market interest.

Full Press Release Details

Wilmington, DE, July 11, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will host an investor conference call and live webcast to discuss its second quarter 2023 financial results on Thursday August 3, 2023 at 8:30 a.m. Eastern Time and will issue a press release earlier that morning. A presentation related to the call will be available at www.enovis.com in the “Investors” section.
Conference call/Webcast Information
Investors can access a live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 630-1956 (U.S. callers) and (412) 317-1837 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Vice President, Investor Relations
Source: Enovis Corporation

Frequently Asked Questions

When is Enovis's Q2 2023 conference call scheduled?

Enovis's Q2 2023 conference call is on August 3, 2023, at 8:30 a.m. ET.

How can investors join the Enovis conference call?

Investors can call (833) 630-1956 for U.S. callers or (412) 317-1837 for international callers.

Where can I find the presentation for the investor call?

The presentation will be available in the 'Investors' section on www.enovis.com.

What is Enovis Corporation known for?

Enovis Corporation specializes in innovation-driven medical technologies for better patient outcomes.

What stock symbol is used for Enovis on the NYSE?

Enovis's shares are listed on the NYSE under the symbol ENOV.

Last updated: Jul 11, 2023